Extracapsular Dissection versus Superficial Parotidectomy for Treatment of Benign Parotid Tumors

Mohamed Korany^1, and Ahmed Said²

¹Department of Surgery, Assiut University, Egypt

²Department of Surgical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

Cite this paper:
Mohamed Korany and Ahmed Said. Extracapsular Dissection versus Superficial Parotidectomy for Treatment of Benign Parotid Tumors. Global Journal of Surgery. 2015; 3(2):27-30. doi: 10.12691/js-3-2-3

Abstract

Objective: The current study aimed to compare extracapsular dissection (ED) versus superficial parotidectomy (SP) in surgical treatment of benign parotid tumors. Methodology: Thirty two patients with benign parotid tumors were included in this study. The patients divided into two groups: the ED group (16) patients (5 males and 11 females) and SP group 16 patients (7 males and 9 females). Patients were followed up for 2 years. Results: Sixteen were included in (ED) group and 16 in (SP) group, twelve patients were males (37.5%) and 20 patients were females (62.5%). The mean age was 47.2 years (range 21 to 69 years) in both groups. No complications developed in (ED) group except wound infections in 2 patients (12.5%). Many cases complicated in (SP) group: two cases of temporary facial paresis, (12.5%), 3 cases of salivary fistula (18.7%), 10 cases (62.5) of cosmetic deformity in the form of depressions in the parotid region and one patient (6.2%) developed Frey's syndrome. No recurrence in either group. Conclusion: Extracapsular dissection is safe and reliable procedure compared to superficial parotidectomy with reduced morbidity and good cosmetic results.

Keywords:
extracapsular dissection parotid superficial parotidectomy

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Smith SL, Komisar A. Limited parotidectomy the role of extra capsular dissection in parotid gland neoplasms. Laryngoscope. 2007; 117: 1163-7.
[2]	Leverstein H, Van der Wal JE, Tiwari RM. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br. J Surg. 1997; 84: 399-403.
[3]	Woods JE, Chong GC, Beahrs OH. Experience with 1,360 primary parotid tumors. Am. J Surg. 1975; 130: 460-2.
[4]	Renehan A, Gleave EN, Hancok BD. Long term follow up of over 1000 patients with salivary gland tumors treated in a single center. Br. J Surg. 1996; 83: 1750-4.
[5]	Long don J. The significance of the tumor capsule in pleomorphic adenoma: the changing face of conventional principles. In controversies in the management of salivary gland disease, McGurk M, Remehan AG (eds) pp. 67-73. Oxford 2001; Oxford University press.
[6]	Leave G. An alternative to superficial parotidectomy: extracapsular dissection. In colour Atlas and Text of salivary glands: Diseases, Disorders and surgery, de Burgh Norman J, McGurk M. (eds) pp 165-72. London 1995 Mosby-wolf.
[7]	Lawson HH: Capsular penetration and perforation in pleomorphic adenoma of the parotid salivary gland. Br. J Surg. 1989; 76: 594-6.
[8]	Patey DH, Thackary AC. The treatment of parotid tumors in the light of a pathological study of parotidectomy material. Br. J Surg. 1958; 45: 477-87.
[9]	Janes RM. The treatment of tumors of the salivary gland by radical excision. Can. Med. Assoc. J 1940; 43: 554-9.
[10]	Guntinas-Lichius O, Kick C. Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. Eur. Arch. Otorhinolaryng. 2014; 261: 143-6.
[11]	Zernial O, Springer IN, Warnke P. Long term recurrence rate of pleomorphic adenoma and postoperative facial nerve paresis (in parotid surgery). J Craniomaxillofac. Surg. 2007; 35: 189-192.
[12]	Hancock BD. Clinically benign parotid Tumors: local dissection as an alternative to superficial parotidectomy in selected cases. Ann. R. Coll. Surg. England. 1999; 81: 299-301.
[13]	Makeieff M, Pelliccia P, Letois F. Recurrent pleomorphic adenoma: results of surgical treatment. Ann. Surg. Oncol. 2010; 17 (12): 3308-13.
[14]	McGurk M, Renehan A, Gleave EN. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenoma. Br. J Surg. 1996; 83 (12): 1747-9.
[15]	Dell’Aversana Orabona G, Bonavolontà P, Iaconetta G. Surigical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy –our experience in 232 cases. J Oral Maxillofac. Surg. 2013; 71(2):410-3.
[16]	Klinsworth N, Zrok J, Koch M. Postoperative complications after extracapsular dissection of benign parotid lesions with particular reference to facial nerve function. Laryngoscope. 2010; 120, 484-90.
[17]	Witt R. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 2002; 112: 2141-5.